|
 DELTA Technical Report
Drug Expenditure Longitudinal Trend Analysis
• First and most comprehensive study of the ODB
• Over 100 pages of analysis, tables and charts
The Ontario Drug Benefit [ODB] program is the largest drug plan in Ontario, accounting for 40% of all prescription drug spending and covers prescription costs for 2.15 million claimants annually.
Combined ODB and claimant costs increased by 57% from $1.1 billion in 1992 to $1.7 billion in 1998 despite little change in the number of claimants.
In-depth analysis of disease categories. Cardiovascular drugs accounted for 48% of the cost increase since 1992. Drugs to treat psychotherapeutic and neurological disorders contributed the second largest portion of the increase at 19%.
View the DELTA Report table of contents.
View the DELTA Summary Report for more details.
Report Authors: Brogan Inc.
Contributors:
Institute for Clinical Evaluative Sciences
Centre for Addiction and Mental Health
GlaxoSmithKline
Funding: GlaxoSmithKline
|
DELTA REPORT TABLE OF CONTENTS
|
Chapter 1: The ODB Program and Research Methodology
• The ODB Program
• Factors Affecting Drug Utilization
• Data
• Source
• Validation and Adjustments
• Limitations
|
Chapter 2: The ODB Program - Claimants, Claims and Costs
• Introduction
• Claimants
• Total Number of ODB Claimants
• Claimants by Age Groups
• Claimants by Age and Gender
• Claims
• Costs
• Total ODB Cost
• Cost per Claim
• Cost per Claimant
• Cost per Claimant by Age
• Cost per Claimant by Gender and Age
• Comparison of Claimants, Claims, and Cost by Age and Gender
|
Chapter 3: ODB Analysis by Program
• Introduction
• Claimants by Program
• Seniors
• Claimants Under 65 Years of Age
• Trends, Inflow, Outflow and Retention - Program Comparisons
• Claims by Program
• Seniors
• Claimants Under 65 Years of Age
• Cost by Program
• Concentration Analysis
|
Chapter 4: Disease Analysis
• Introduction
• Disease Categories Overview
• Trends
• Analysis by Disease Category
- Cardiovascular
- Psychotherapeutic & Neurological
- Gastrointestinal
- Infectious
- Respiratory
- Musculoskeletal
- Oncology
- All Other Diseases
|
Study 1: Antipsychotic Drug Use
• A Demographic Overview of Typical and Atypical Antipsychotic Drug Use
|
Study 2: Insomnia & Anxiety Drug use
• An Analysis of Long Acting Benzodiazepine Use in the ODB
|
|
